All Stories

  1. A new parameter of growth inhibition for cell proliferation assays

    Article • Journal of Cellular Physiology, December 2017, Wiley

    Francesco Paolo Fiorentino

  2. 12-O-tetradecanoylphorbol-13-acetate and EZH2 inhibition: A novel approach for promoting myogenic differentiation in embryonal rhabdomyosarcoma cells

    Article • Journal of Cellular Physiology, August 2017, Wiley

    Francesco Paolo Fiorentino

  3. Design of a Lentiviral Vector for the Inducible Expression of MYC: A New Strategy for Construction Approach

    Article • Molecular Biotechnology, April 2017, Springer Science + Business Media

    Francesco Paolo Fiorentino

  4. MYCL is a target of a BET bromodomain inhibitor, JQ1, on growth suppression efficacy in small cell lung cancer cells

    Article • Oncotarget, November 2016, Impact Journals, LLC

    Francesco Paolo Fiorentino

  5. Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation

    Article • Oncotarget, April 2016, Impact Journals, LLC

    Francesco Paolo Fiorentino

  6. On the role of retinoblastoma family proteins in the establishment and maintenance of the epigenetic landscape

    Article • Journal of Cellular Physiology, October 2012, Wiley

    Francesco Paolo Fiorentino

  7. The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation

    Article • Cell Cycle, October 2012, Taylor & Francis

    Francesco Paolo Fiorentino

  8. The tumor suppressor role of CTCF

    Article • Journal of Cellular Physiology, November 2011, Wiley

    Francesco Paolo Fiorentino

  9. Human papillomavirus infection in couples undergoing in vitro fertilization procedures: impact on reproductive outcomes

    Article • Fertility and Sterility, April 2011, Elsevier

    Francesco Paolo Fiorentino

  10. CTCF and BORIS Regulate Rb2/p130 Gene Transcription: A Novel Mechanism and a New Paradigm for Understanding the Biology of Lung Cancer

    Article • Molecular Cancer Research, February 2011, American Association for Cancer Research (AACR)

    Francesco Paolo Fiorentino

  11. Senescence and p130/Rbl2: a new beginning to the end

    Article • BDJ, August 2009, Nature

    Francesco Paolo Fiorentino

  12. The role of Aurora-A inhibitors in cancer therapy

    Article • Annals of Oncology, June 2007, Oxford University Press (OUP)

    Francesco Paolo Fiorentino